Artificial Intelligence (AI) holds the potential to support us in unfolding the complex nature of allergic disease to both help potential development of novel treatments and to empower people living with allergy. Our focus is on using AI technology to assist in clarifying diagnosis and shortening the path to develop innovative treatment solutions.
As a leader in allergy research with data from more than 20 clinical trials and +25 years of lab work, we aim to use data science and AI to lead us towards delivering continued scientific and medical breakthroughs.
One such recent breakthrough is our discovery of the cellular basis of allergic memory paving the way for an improved understanding of allergic disease.
ALK and McMaster researchers discover new cell that remembers allergies | ALK
We are implementing cutting edge data platforms and new tools to enhance our drug discovery pipeline and transform how we:
We are using AI and machine-learning algorithms that may improve the daily lives of people with allergy and serve to understand the global trends in allergy and allergy related diseases.
Through mobile apps and wearable devices, we are exploring new ways of measuring allergic burden with the aim to improve quality of life for the individual patient and assist in guiding them towards optimal treatment.